The Procter & Gamble Company (NYSE:PG) Stock Position Decreased by TD Private Client Wealth LLC

TD Private Client Wealth LLC decreased its stake in The Procter & Gamble Company (NYSE:PG) by 0.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,525 shares of the company’s stock after selling 145 shares during the quarter. TD Private Client Wealth LLC’s holdings in Procter & Gamble were worth $7,539,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Geode Capital Management LLC boosted its holdings in Procter & Gamble by 7.0% in the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares in the last quarter. FMR LLC lifted its holdings in Procter & Gamble by 2.7% in the 3rd quarter. FMR LLC now owns 26,556,319 shares of the company’s stock worth $4,599,554,000 after purchasing an additional 689,282 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Procter & Gamble by 0.6% in the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after purchasing an additional 122,190 shares during the period. Fisher Asset Management LLC raised its stake in Procter & Gamble by 4.7% during the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock valued at $3,183,522,000 after purchasing an additional 830,476 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Procter & Gamble by 0.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 16,422,470 shares of the company’s stock valued at $2,844,442,000 after buying an additional 105,734 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on PG shares. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research note on Monday, September 30th. Wells Fargo & Company increased their price objective on Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 22nd. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. DA Davidson raised Procter & Gamble from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $160.00 to $209.00 in a report on Monday, November 25th. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $180.45.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $172.38 on Wednesday. The stock’s 50 day moving average is $170.71 and its 200-day moving average is $169.44. The company has a market capitalization of $405.96 billion, a price-to-earnings ratio of 29.72, a PEG ratio of 3.68 and a beta of 0.44. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.83 EPS. Equities research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.34%. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Buying and Selling

In related news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 83,080 shares of company stock worth $14,629,038 in the last ninety days. 0.18% of the stock is owned by insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.